BRAF-Mutated Microsatellite Stable (MSS) Colorectal Carcinoma: An Aggressive Adenocarcinoma with Reduced CDX2 and Increased Cytokeratin 7 Immunohistochemical Expression

被引：0
|
作者：
Landau, M. [1 ]
Kuan, S-F [1 ]
Chiosea, S. [1 ]
Pai, R. K. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
760
引用
收藏
页码：187A / 187A
页数：1
相关论文
共 23 条
  • [1] BRAF-Mutated Microsatellite Stable (MSS) Colorectal Carcinoma: An Aggressive Adenocarcinoma with Reduced CDX2 and Increased Cytokeratin 7 Immunohistochemical Expression
    Landau, M.
    Kuan, S-F
    Chiosea, S.
    Pai, R. K.
    MODERN PATHOLOGY, 2014, 27 : 187A - 187A
  • [2] BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression
    Landau, Michael S.
    Kuan, Shih-Fan
    Chiosea, Simon
    Pai, Reetesh K.
    HUMAN PATHOLOGY, 2014, 45 (08) : 1704 - 1712
  • [3] BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Features
    Pai, Reetesh K.
    Jayachandran, Priya
    Koong, Albert C.
    Chang, Daniel T.
    Kwok, Shirley
    Ma, Lisa
    Arber, Daniel A.
    Balise, Raymond R.
    Tubbs, Raymond R.
    Shadrach, Bonnie
    Pai, Rish K.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (05) : 744 - 752
  • [4] The Diagnostic Value of Cadherin 17 and CDX2 Expression as Immunohistochemical Markers in Colorectal Adenocarcinoma
    Mariam B. Abouelkhair
    Shadia H. Mabrouk
    Sahar S. A. Zaki
    Ola H. Nada
    Sarah A. Hakim
    Journal of Gastrointestinal Cancer, 2021, 52 : 960 - 969
  • [5] The Diagnostic Value of Cadherin 17 and CDX2 Expression as Immunohistochemical Markers in Colorectal Adenocarcinoma
    Abouelkhair, Mariam B.
    Mabrouk, Shadia H.
    Zaki, Sahar S. A.
    Nada, Ola H.
    Hakim, Sarah A.
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (03) : 960 - 969
  • [6] CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal Carcinoma
    Slik, Khadija
    Turkki, Riku
    Carpen, Olli
    Kurki, Samu
    Korkeila, Eija
    Sundstrom, Jari
    Pellinen, Teijo
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (11) : 1473 - 1482
  • [7] Colorectal carcinoma (CRC) stage II: Evaluation of CDX2 expression and microsatellite instability (MSI) as potential biomarkers
    Pilozzi, E.
    Roberto, M.
    Quacquarini, D.
    Di Fede, L.
    Di Cerbo, A.
    Falcone, R.
    Vecchione, G.
    Marchetti, P.
    Ruco, L.
    Romiti, A.
    VIRCHOWS ARCHIV, 2017, 471 : S185 - S185
  • [8] Diagnostic utility of immunohistochemical expression of Cdx2 and cytokeratin (CK)7/20 in metastatic carcinomas of the ovary from gastrointestinal tract
    Ha, HI
    Lee, HI
    Kim, MJ
    Ro, JY
    Kim, KR
    LABORATORY INVESTIGATION, 2005, 85 : 185A - 185A
  • [9] Diagnostic utility of immunohistochemical expression of Cdx2 and cytokeratin (CK)7/20 in metastatic carcinomas of the ovary from gastrointestinal tract
    Ha, HI
    Lee, HI
    Kim, MJ
    Ro, JY
    Kim, KR
    MODERN PATHOLOGY, 2005, 18 : 185A - 185A
  • [10] Cytokeratin 7 is Superior to Lineage-Specific Markers SATB2, CDX2, and Villin in Distinguishing Primary Pulmonary Mucinous Adenocarcinoma from Metastatic Colorectal Carcinoma
    Meyerson, Cherise
    Fishbein, Gregory
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1803 - 1804
123